Patricia Lynn Allen, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 1129 S San Gabriel Blvd, San Gabriel, CA 91776 Phone: 626-287-6746 Fax: 626-827-8357 |
David C P Chen, Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1129 S San Gabriel Blvd, San Gabriel, CA 91776 Phone: 626-282-2802 Fax: 626-282-2202 |
Dr. Maximilian Yue Cho, M.D. Radiology - Neuroradiology Medicare: Accepting Medicare Assignments Practice Location: 110 W Las Tunas Dr Ste A, San Gabriel, CA 91776 Phone: 626-244-8200 |
News Archive
Medical students give the U.S. healthcare system a poor grade and consider technology a ‘must have' for their future practice. These opinions and technology priorities, including mobile reference and electronic medical records (EMRs), are represented in the fourth annual Future Physicians of America survey by Epocrates, Inc., the leading provider of mobile medical technology.
Now that the Supreme Court has agreed to hear a dispute over the federal health care law, the justices are facing the strongest challenge to their ban on televised hearings. Members of Congress and news industry leaders have asked the court to allow the televising of oral arguments, to be held over five and a half hours during two days in March.
Some current therapies being investigated for Alzheimer's disease may cause further neural degeneration and cell death, according to a breakthrough discovery by UC San Diego researchers. By combining three dimensional computer simulations with high resolution atomic force microscopy membrane protein and cell imaging, electrical recording and various cellular assays, UCSD nano-biophysicist Ratnesh Lal and his colleagues investigated the structure and function of truncated peptides, known as nonamyloidgenic peptides, formed by some Alzheimer's drug candidates.
Researchers of Ghent University - department of Food Safety and food Quality developped a technique to to reduce acrylamide in French fries on an industrial scale. Acrylamide is a product that may cause cancer and was discovered in various foods.
NovaBay® Pharmaceuticals, Inc. (NYSE Amex: NBY) announced today that it has closed its previously announced registered direct offering of 1,225,000 units, with each unit consisting of (i) one share of the NovaBay common stock, par value $0.01 per share, and (ii) one warrant to purchase one share of NovaBay common stock.
› Verified 4 days ago